Clodronic acid/Hyaluronic acid

氯膦酸/透明质酸

Report date: 2022/10/19 15:11:56

Base Information

Drug NameClodronic acid/Hyaluronic acid
Drug Alias NameHyaluronic acid+Clodronic acid透明质酸+氯膦酸氯膦酸+透明质酸Hyaluronic acid/Clodronic acidClodronic acid+Hyaluronic acid
ClassificationSmall molecules
Mechanisms of ActionCD44 antigen modulatorsBone resorption factor inhibitors
TargetsBone resorption factorCD44 antigen
Therapy Area/IndicationsOsteoarthritis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsYes Clodronate DisodiumHyaluronic acid inhalation (Actelion Pharmaceuticals)
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAbiogen Pharma Spa
China Registration ClassN/A

Develop Information

Active CompaniesAbiogen Pharma Spa
Inactive CompaniesN/A
Active IndicationsOsteoarthritis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A